As a hi-tech executive, I was transferred by IBM to Silicon Valley from Michigan and I absolutely loved it here. My wife, a networking industry professional, and I are raising our two boys and found our American dream in Saratoga. We also discovered deep joy in giving back, solving the problems of our community and helping to better people's lives. That is why I am running for Congress.
As a Mechanical Engineer, elected leader and community activist I was keenly interested in tackling tough challenges and delivering results. I reduced burglaries, defeated many San Jose Water Company rate hikes, challenged PG&E’s gutting of California’s solar program, pushed for the audit of HCD’s RHNA numbers, stopped a massive hotel in an environmentally sensitive zone, and stopped a road repair tax, favoring fiscal optimization measures.
My run for Congress is about bringing back integrity and a getting-things-done approach to political office. It is about reducing crime, inflation/gas prices, championing Medicare for All, legislating Pro-Choice, and cleaning up Washington by rejecting Special Interest money and influence. I would be honored to have your vote in the primary election of June 7, 2022.
The establishment has made their choice but the pandemic has spotlit inequities in healthcare and decades of climate action failure. There’s a better choice.....
Rishi Kumar is the only candidate who supports Medicare for All, period. He is Pro-Choice and has a real plan for Climate.
He’s the best choice and our endorsement for Congress in the new District 16.
Anna Eshoo is currently the largest recipient of drug company money. She’s addicted to drug company money. An array of corporate interests and their allies in the U.S. Congress are seeking to block the Medicare for All legislation. Anna Eshoo is one of the closest allies of the interests opposing this legislation.
Anna Eshoo’s record on drug prices is terrible, and the reason why is obvious. She’s taken enormous sums of money from drug corporations, and she does their bidding in Washington.
In Congress, Eshoo has consistently voted in favor of the (Pharma) industry.
Eshoo’s bill establishes a 12-year marketing monopoly for brand-name biologics, apart from patent protection. Even worse, it rewards branded biologic drug manufacturers with additional years of exclusivity if they make slight changes to their existing drugs, a strategy known as ‘evergreening’.
A scathing report by the Federal Trade Commission in June said no added protection, much less 12 years, was warranted... Eshoo legislation would ensure sky-high drug prices and stifle innovation
Democratic challenger Kumar has campaigned on getting big money out of politics, pointing to the significant corporate lobbying directed at Eshoo. In her career, Eshoo has accepted close to $1.8 million in contributions — more than any other member of the House — from PACs for and individuals affiliated with the pharmaceutical industry. She is currently the Chairwoman of the Subcommittee on Health, tasked with regulating pharmaceuticals.
Eshoo responded to this critique in a statement to The Daily, admitting she received significant contributions from the health care community. --SNIP SNIP--. Nevertheless, we are concerned by the donations she has accepted from the pharmaceutical industry.
